The Inflammatory Cytokines
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 52 (Supplement), 9-17
- https://doi.org/10.2165/00003495-199600522-00004
Abstract
Bacterial products [lipopolysaccharide (LPS) with Gram-negative bacteria and toxins, superantigens or cell wall fragments with Gram-positive bacteria] are the main activators of the septic shock...Keywords
This publication has 22 references indexed in Scilit:
- Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide).The Journal of Immunology, 1995
- A second large controlled clinical study of E5, a monoclonal antibody to endotoxinCritical Care Medicine, 1995
- Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.1995
- Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activationJournal of Biological Chemistry, 1994
- Recognition of endotoxin by cells leading to transmembrane signalingCurrent Opinion in Immunology, 1994
- Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.The Journal of Immunology, 1993
- Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.The Journal of Immunology, 1992
- A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbitsThe FASEB Journal, 1991
- Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequencesCytokine, 1990
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987